Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Zhejiang Hisun’s FDA import alert; a new chapter in the fight against data integrity
A few months ago, PharmaCompass covered
the Health Canada request to quarantine drugs linked to lead
Mylan’s great Indian misadventure
News about Mylan N.V.’s US $ 1.6 billion cash acquisition of Agila Specialties Private Limited
